BioCentury
ARTICLE | Financial News

Chinese CAR T play JW raises $90M series A

March 8, 2018 4:00 AM UTC

JW Therapeutics (Shanghai) Co. Ltd. (Shanghai, China) raised $90 million in a series A round led by Temasek, Sequoia Capital China and Yuanming Capital. Fellow new investors Oriza Seed Capital, Yipu Capital, AVICT Global Holdings, Shiyu Capital and LVC Capital Fund also participated, as did existing investors WuXi AppTec Co. Ltd. (Shanghai, China) and Juno Therapeutics Inc., which Celgene Corp. (NASDAQ:CELG) acquired (see BioCentury, March 8).

WuXi and Juno launched JW in 2016 to develop immuno-oncology cell therapies in China (see BioCentury Extra, April 7, 2016). ...